Skip to content
← Full study record

NCT02773030 · OUTCOME

Overall Survival for Cohort D, Cohort H2 and Cohort I

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma · Source last updated 2026-03-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Weeks
Interval / dispersion
Full Range
Time frame
On Average of (Cohort D: 81.14 Cohort H2: 91.54 Cohort I: 74.20)Weeks

What was measured

Time from first dose of IP to death due to any cause Data will be collected and analyzed per Cohort Totals.

Analysis population: Safety Population for Cohort D, Cohort H2 and Cohort I - as per protocol, the individual arms in the cohort would be combined for OS presentation

Groups in this outcome

Cohort D: Total

CC220

Cohort H2

CC220 + DEX

Cohort I

CC220 + DEX

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort D: Total107
Cohort H25
Cohort I41

Reported measurements

Source class 1
Values in Weeks · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Cohort D: Total44.29Not reported1.9228.0Not reported
Cohort H2103.43Not reported19.9147.0Not reported
Cohort I60.43Not reported6.6210.6Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        1.9
        upper Limit
        228.0
        value
        44.29
      2. group Id
        OG001
        lower Limit
        19.9
        upper Limit
        147.0
        value
        103.43
      3. group Id
        OG002
        lower Limit
        6.6
        upper Limit
        210.6
        value
        60.43
denoms
  1. counts
    1. group Id
      OG000
      value
      107
    2. group Id
      OG001
      value
      5
    3. group Id
      OG002
      value
      41
    units
    Participants
description
Time from first dose of IP to death due to any cause Data will be collected and analyzed per Cohort Totals.
dispersion Type
Full Range
groups
  1. description
    CC220
    id
    OG000
    title
    Cohort D: Total
  2. description
    CC220 + DEX
    id
    OG001
    title
    Cohort H2
  3. description
    CC220 + DEX
    id
    OG002
    title
    Cohort I
param Type
MEDIAN
population Description
Safety Population for Cohort D, Cohort H2 and Cohort I - as per protocol, the individual arms in the cohort would be combined for OS presentation
reporting Status
POSTED
time Frame
On Average of (Cohort D: 81.14 Cohort H2: 91.54 Cohort I: 74.20)Weeks
title
Overall Survival for Cohort D, Cohort H2 and Cohort I
type
SECONDARY
unit Of Measure
Weeks

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice